<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-2019-5-877-884</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-1730</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>РОЛЬ ФАКТОРОВ АНГИОГЕНЕЗА В ТРАНСПЛАЦЕНТАРНОЙ ПЕРЕДАЧЕ АНТИТЕЛ К ВИРУСУ КОРИ</article-title><trans-title-group xml:lang="en"><trans-title>ROLE OF ANGIOGENIC FACTORS FOR TRANSPLACENTAL TRANSFER OF THE MEASLES ANTIBODIES</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7280-6877</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шмитько</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Shmitko</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шмитько Анна Дмитриевна, к.м.н., старший научный сотрудник лаборатории вакцинопрофилактики и иммунотерапии аллергических заболеваний </p><p>105064, Россия, Москва, Малый Казенный пер., 5а.</p><p>Тел.: 8 (495) 917-41-49.</p></bio><bio xml:lang="en"><p>Shmitko Anna D., PhD (Medicine), Senior Research Associate, Laboratory of Vaccination and Immunotherapy of Allergic Diseases</p><p>105064, Russian Federation, Moscow, Malyi Kazennyi lane, 5a.</p><p>Phone: 7 (495) 917-41-49.</p></bio><email xlink:type="simple">violadellanna@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1382-9403</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Костинов</surname><given-names>М. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Kostinov</surname><given-names>M. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, заслуженный деятель науки РФ, заведующий лабораторией вакцинопрофилактики и иммунотерапии ФГБНУ НИИВС им. И.И. Мечникова; профессор кафедры эпидемиологии ИПО Первого МГМУ им. И.М. Сеченова МЗ РФ</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Honored Science Worker of Russia, Head, Laboratory of Vaccination and Immunotherapy of Allergic Diseases; Professor, Department of Epidemiology</p></bio><email xlink:type="simple">vaccinums@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0533-0909</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полищук</surname><given-names>В. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Polyschuk</surname><given-names>V. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., старший научный сотрудник лаборатории вакцинопрофилактики и иммунотерапии аллергических заболеваний</p></bio><bio xml:lang="en"><p>PhD (Medicine), Senior Research Associate, Laboratory of Vaccination and Immunotherapy of Allergic Diseases</p></bio><email xlink:type="simple">vaccinums@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3217-2029</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сависько</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Savisko</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., доцент кафедры пропедевтики детских болезней</p></bio><bio xml:lang="en"><p>PhD (Medicine), Associate Professor, Department of Propedeutics of Pediatric Diseases</p></bio><email xlink:type="simple">vaccinums@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8350-6896</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильева</surname><given-names>Г. В. </given-names></name><name name-style="western" xml:lang="en"><surname>Vasilieva</surname><given-names>G. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>младший научный сотрудник лаборатории вакцинопрофилактики и иммунотерапии аллергических заболеваний</p></bio><bio xml:lang="en"><p>Junior Research Associate, Laboratory of Vaccination and Immunotherapy of Allergic Diseases</p></bio><email xlink:type="simple">vaccinums@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт вакцин и сывороток имени И.И. Мечникова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I. Mechnikov Research Institute of Vaccines and Sera</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт вакцин и сывороток имени И.И. Мечникова»; ФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Министерства здравоохранения РФ (Сеченовский университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I. Mechnikov Research Institute of Vaccines and Sera; First Moscow State I. Sechenov Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ростовский государственный медицинский университет» Министерства здравоохранения РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>09</day><month>12</month><year>2019</year></pub-date><volume>21</volume><issue>5</issue><fpage>877</fpage><lpage>884</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шмитько А.Д., Костинов М.П., Полищук В.Б., Сависько А.А., Васильева Г.В., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Шмитько А.Д., Костинов М.П., Полищук В.Б., Сависько А.А., Васильева Г.В.</copyright-holder><copyright-holder xml:lang="en">Shmitko A.D., Kostinov M.P., Polyschuk V.B., Savisko A.A., Vasilieva G.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/1730">https://www.mimmun.ru/mimmun/article/view/1730</self-uri><abstract><p>Факторы ангиогенеза (VEGF, Ang-1, TGF-β) влияют на формирование, развитие и функционирование эндотелиальных клеток сосудов, входящих в структуру гистологического плацентарного барьера и участвующих в трансплацентарной передаче веществ. Целью исследования явилось изучение взаимосвязи концентрации VEGF, Ang-1, TGF-β и уровня трансплацентарных IgG-антител к вирусу кори в пуповинной крови детей, рожденных матерями с плацентарной недостаточностью. В венозной крови 32 женщин с неосложненной беременностью и 34 – с плацентарной недостаточностью, а также пуповинной крови их новорожденных методом ИФА был исследован уровень IgG-антител к вирусу кори и концентрация факторов ангиогенеза (VEGF, Ang-1, TGF-β). В пуповинной крови серонегативных к вирусу кори младенцев, рожденных женщинами с плацентарной недостаточностью, установлен одинаково низкий уровень VEGF, снижение концентрации Ang-1 (1,6 раза) и повышение TGF-β (2,7 раза) по сравнению с серопозитивными новорожденными. У аналогичной группы детей от матерей с физиологическим течением беременности уровень данных факторов не отличался от таковых у новорожденных, имеющих протективные антитела к кори. При неосложненном течении беременности трансплацентарная передача IgG к вирусу кори находится в прямой зависимости от наличия специфических антител у женщины, при плацентарной недостаточности дисбаланс в системе факторов ангиогенеза может способствовать нарушению механизмов трансмиссии IgG-антител к вирусу кори от матери плоду.</p></abstract><trans-abstract xml:lang="en"><p>Angiogenesis factors (VEGF, Ang-1, TGF-β) influence production, development and functioning of vascular endothelium that are part of the placental barrier structure and are involved into transplacental transfer of different substances. The aim of this study was to study the relationship between VEGF, Ang-1, and TGF-β concentrations, and the levels of transplacental IgG-antibodies to the measles virus in cord blood of children born to mothers with placental insufficiency. Patients and methods: venous blood was taken from 32 women with uncomplicated pregnancies, and 34 samples from pregnant women with placental insufficiency, as well as umbilical blood of their newborns, the level of IgG-antibodies to measles and the concentration of some angiogenic factors (VEGF, Ang-1, TGF-β) examined by ELISA techniques. The following results were obtained: in a cord blood of infants seronegative for the measles virus, born to women with placental insufficiency, showed uniformly low VEGF levels, decreased Ang-1 concentration (1.6) and increased TGF-β concentration (2.7) as compared to seropositive newborns. In a similar group of children from mothers with physiological pregnancy, the level of these factors did not differ from those in newborns with protective antibodies to measles. Conclusion: in physiological pregnancy, transplacental transmission of IgG-antibodies to the measles virus is directly dependent on the presence of specific antibodies in a woman; in case of placental insufficiency, an imbalance in the system of angiogenic factors may promote disturbances of transmission mechanisms for IgG measles-specific antibodies from mother to the fetus.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>корь</kwd><kwd>вакцинация</kwd><kwd>факторы ангиогенеза</kwd><kwd>VEGF</kwd><kwd>Ang-1</kwd><kwd>TGF-β</kwd><kwd>трансплацентарные антитела</kwd><kwd>новорожденные</kwd></kwd-group><kwd-group xml:lang="en"><kwd>measles</kwd><kwd>vaccination</kwd><kwd>angiogenesis factors</kwd><kwd>VEGF</kwd><kwd>Ang-1</kwd><kwd>TGF-β</kwd><kwd>transplacental antibodies</kwd><kwd>newborns</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бочарова И.И., Костинов М.П., Новикова С.В., Шмитько А.Д., Обидина А.А., Цивцивадзе Е.Б. Трансплацентарные антитела к вирусу кори у новорожденных при различном течении беременности у их матерей // Российский вестник акушера-гинеколога, 2014. Т. 2, № 14. С. 14-18.</mixed-citation><mixed-citation xml:lang="en">Bocharova I.I., Kostinov M.P., Novikova S.V., Shmitko A.D., Obidina A.A., Tsivtsivadze E.B. Transplacental antibodies to measles virus in neonatal infants during different pregnancies in their mothers. Rossiyskiy vestnik akushera-ginekologa = Russian Bulletin of Obstetrician-Gynaecologist, 2014, Vol. 2, no. 14, pp. 14-18. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Зверев В.В., Хаитов Р.М. Вакцины и вакцинация. Национальное руководство. Краткое издание / под ред. В.В. Зверева, Р.М. Хаитова. М.: ГЭОТАР-Медиа, 2014. 640 с.</mixed-citation><mixed-citation xml:lang="en">Zverev V.V., Khaitov R.M. Vaccines and vaccination. National leadership. Brief Edition. Ed. by V.V. Zverev, R.M. Khaitov. Moscow: GEOTAR-Media, 2014. 640 p.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Инфекционная заболеваемость в Российской Федерации за январь-апрель 2018 г. (по данным формы № 1 «Сведения об инфекционных и паразитарных заболеваниях») [Электронный ресурс]: сайт. Режим доступа: http://rospotrebnadzor.ru/activities/statistical-materials/statictic_details.php?ELEMENT_ID=10158 (дата обращения: 18.02.19).</mixed-citation><mixed-citation xml:lang="en">Infectious morbidity in the Russian Federation for January-April 2018 (according to form No. 1 “Information on infectious and parasitic diseases”) [Electronic resource. Access mode: http://rospotrebnadzor.ru/activities/statistical-materials/statictic_details.php?ELEMENT_ID=10158 (date of the application: 18.02.19).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П. Вакцинация детей с нарушенным состоянием здоровья: практическое руководство для врачей. 4-е изд. М.: Медицина для всех, 2013. 431 с.</mixed-citation><mixed-citation xml:lang="en">Kostinov M.P. Vaccination of children with impaired health: a practical guide for doctors. 4 th edition. Moscow: Medicine for All, 2013. 431 p.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Шмитько А.Д., Бочарова И.И., Черданцев А.П., Сависько А.А., Полищук В.Б. Уровень IgG-антител к вирусу кори в пуповинной крови новорожденных с учетом возраста матерей // Эпидемиология и инфекционные болезни, 2014. № 3. С. 30-34.</mixed-citation><mixed-citation xml:lang="en">Kostinov M.P., Shmitko A.D., Bocharova I.I., Cherdancev A.P., Savisko A.A., Polishchuk V.B. Measles virus-specific IgG-antibodies level in umbilical cord blood according to the maternal age. Epidemiologiya i infektsionnye bolezni = Epidemiology and Infectious Diseases, 2014, no. 3, pp. 30-34. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Шмитько А.Д., Соловьева И.Л., Сависько А.А., Полищук В.Б., Рыжов А.А., Черданцев А.П. Необходима ли третья доза вакцины против кори – взгляд иммунолога // Журнал микробиологии, эпидемиологии и иммунобиологии, 2016. № 5. С. 88-94.</mixed-citation><mixed-citation xml:lang="en">Kostinov M.P., Shmitko A.D., Solovyeva I.L., Savisko A.A., Polischuk V.B., Ryzhov A.A., Cherdantsev A.P. Is a third dose of measles vaccine necessary – an immunologist’s view. Zhurnal mikrobiologii, epidemiologii i immunobiologii = Journal of Microbiology, Epidemiology and Immunobiology, 2016, no. 5, pp. 88-94. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Костинов М.П., Шмитько А.Д., Соловьева И.Л., Сависько А.А., Черданцев А.П. Защищены ли от кори дети с аллергическими заболеваниями и часто болеющие после ревакцинации // Педиатрия. Журнал им. Г.Н. Сперанского, 2017. Т. 4, № 96. С. 140-145.</mixed-citation><mixed-citation xml:lang="en">Kostinov M.P., Shmitko A.D., Solovyeva I.L., Savisko A.A., Cherdantsev A.P. Are children with allergic diseases and sickly children resistant to measles after revaccination? Pediatriya. Zhurnal im. G.N. Speranskogo = Pediatrics. Speransky Journal, 2017, Vol. 4, no. 96, pp. 140-145. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Соколов Д.И., Колобов А.В., Лесничная М.В., Костючек И.Н., Баля К.В., Аржанова О.Н., Кветной И.М., Сельков С.А. Роль проангиогенных и антиангиогенных факторов в развитии плаценты // Медицинская иммунология, 2008. Т. 10, № 4-5. С. 347-352. doi: 10.15789/1563-0625-2008-4-5-347-352.</mixed-citation><mixed-citation xml:lang="en">Sokolov D.I., Kolobov A.V., Lesnichnaya M.V., Kostyuchek I.N., Balya K.V., Arzhanova O.N., Kvetnoy I.M., Selkov S.A. Role of pro-and antiangiogenic factors in placental development. Meditsinskaya immunologiya = Medical Immunology (Russia), 2008, Vol. 10, no. 4-5, pp. 347- 352. (In Russ.) doi: 10.15789/1563-0625-2008-4-5-347-352.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Соколов Д.И., Сельков С.А. Иммунологический контроль формирования сосудистой сети плаценты: монография. СПб.: Н-Л, 2012. 208 с.</mixed-citation><mixed-citation xml:lang="en">Sokolov D.I., Selkov S.A. Immunological control of the formation of vascular network of a placenta: monograph. St. Petersburg: N-L, 2012. 208 p.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Соловьева И.Л., Костинов М.П., Кусельман А.И. Особенности вакцинации детей с измененным преморбидным фоном против гепатита В, кори, эпидемического паротита. Ульяновск: УлГУ, 2006. 295 с.</mixed-citation><mixed-citation xml:lang="en">Solovyeva I.L., Kostinov M.P., Kuselman A.I. Features of vaccination of children with a modified premorbid background against hepatitis B, measles, and mumps. Ulyanovsk: Ulyanovsk State University, 2006. 295 p.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Шмитько А.Д., Костинов М.П., Бочарова И.И., Сависько А.А., Магаршак О.О., Полищук В.Б. Трансплацентарные IgG к вирусу кори в пуповинной крови у новорожденных разных регионов Российской Федерации // Журнал микробиологии, эпидемиологии и иммунобиологии, 2015. № 1. С. 52-57.</mixed-citation><mixed-citation xml:lang="en">Shmitko A.D., Kostinov M.P., Bocharova I.I., Savisko A.A., Magarshak O.O., Polischuk V.B. Transplacental IgG against measles virus in umbilical blood of neonates from various regions of Russian Federation. Zhurnal mikrobiologii, epidemiologii i immunobiologii = Journal of Microbiology, Epidemiology and Immunobiology, 2015, no. 1, pp. 52-57. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Barut F., Barut A., Gun B.D., Ozdamamr S. Intrauterine growth restriction and placental angiogenesis. J. Diagn. Pathol., 2010, no. 5, p. 24.</mixed-citation><mixed-citation xml:lang="en">Barut F., Barut A., Gun B.D., Ozdamamr S. Intrauterine growth restriction and placental angiogenesis. J. Diagn. Pathol., 2010, no. 5, p. 24.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Borras D., Perales-Puchalt A., Ruiz Sacedón N., Perales A. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated with intrauterine growth restriction. J. Obstet. Gynaecol., 2014, Vol. 34, no. 3, pp. 218-220.</mixed-citation><mixed-citation xml:lang="en">Borras D., Perales-Puchalt A., Ruiz Sacedón N., Perales A. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated with intrauterine growth restriction. J. Obstet. Gynaecol., 2014, Vol. 34, no. 3, pp. 218-220.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Charnock-Jones D.S., Kaufmann P., Mayhew T.M. Aspects of human fetoplacental vasculogenesis and angiogenesis. Placenta, 2004, Vol. 25, no. 2-3, pp. 103-113.</mixed-citation><mixed-citation xml:lang="en">Charnock-Jones D.S., Kaufmann P., Mayhew T.M. Aspects of human fetoplacental vasculogenesis and angiogenesis. Placenta, 2004, Vol. 25, no. 2-3, pp. 103-113.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">ECDC: Check your vaccination status before the holiday season [Электронный ресурс]: сайт. Режим доступа: https://ecdc.europa.eu/en/news-events/ecdc-check-your-vaccination-status-holiday-season (дата обращения: 18.02.19).</mixed-citation><mixed-citation xml:lang="en">ECDC: Check your vaccination status before the holiday season [Electronic resource. Access mode: https://ecdc.europa.eu/en/news-events/ecdc-check-your-vaccination-status-holiday-season (date of the application: 18.02.19).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Einarsdottir H.K., Selman M.H.J., Kapur R., Scherjon S., Koeleman C.A.M., Deelder A.M., van der Schoot C.E., Vidarsson G., Wuhrer M. Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G. Glycoconj. J., 2013, Vol. 30, no. 2, pp. 147-157.</mixed-citation><mixed-citation xml:lang="en">Einarsdottir H.K., Selman M.H.J., Kapur R., Scherjon S., Koeleman C.A.M., Deelder A.M., van der Schoot C.E., Vidarsson G., Wuhrer M. Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G. Glycoconj. J., 2013, Vol. 30, no. 2, pp. 147-157.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ellinger I., Fuchs R. hFcRn-mediated transplacental immunoglobulin G transport: Protection of and thrust to the human fetus and newborn. Wiener Medizinische Wochenschrift, 2012, Vol. 162, no. 9-10, pp. 207-213.</mixed-citation><mixed-citation xml:lang="en">Ellinger I., Fuchs R. hFcRn-mediated transplacental immunoglobulin G transport: Protection of and thrust to the human fetus and newborn. Wiener Medizinische Wochenschrift, 2012, Vol. 162, no. 9-10, pp. 207-213.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Enquobahrie D.A., Williams M.A., Qiu C., Woelk G.B., Mahomed Kassam. Maternal plasma transforming growth factor-beta1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women. J. Matern. Fetal. Neonatal. Med., 2005, no. 17, pp. 343-348.</mixed-citation><mixed-citation xml:lang="en">Enquobahrie D.A., Williams M.A., Qiu C., Woelk G.B., Mahomed Kassam. Maternal plasma transforming growth factor-beta1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women. J. Matern. Fetal. Neonatal. Med., 2005, no. 17, pp. 343-348.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">For Healthcare Professionals [Электронный ресурс]: сайт. Режим доступа: https://www.cdc.gov/measles/hcp/index.html (дата обращения: 18.02.19).</mixed-citation><mixed-citation xml:lang="en">For Healthcare Professionals [Electronic resource. Access mode: URL: https://www.cdc.gov/measles/hcp/index.html (date of the application: 18.02.19]).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Monthly measles and rubella monitoring report [Электронный ресурс. Режим доступа: https://www.ecdc.europa.eu/sites/portal/files/documents/measles-rubella-monthly-monitoring-report-november-2018.pdf (дата обращения: 18.02.19).</mixed-citation><mixed-citation xml:lang="en">Monthly measles and rubella monitoring report [Electronic resource. Access mode: https://www.ecdc.europa.eu/sites/portal/files/documents/measles-rubella-monthly-monitoring-report-november-2018.pdf (date of the application: 18.02.19).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Palmeira P., Quinello C., Silveira-Lessa A.L., Zago C.A., Carneiro-Sampaio M. IgG placental transfer in healthy and pathological pregnancies (review article). Clin. Dev. Immunol., 2012, 985646. doi: 10.1155/2012/985646.</mixed-citation><mixed-citation xml:lang="en">Palmeira P., Quinello C., Silveira-Lessa A.L., Zago C.A., Carneiro-Sampaio M. IgG placental transfer in healthy and pathological pregnancies (review article). Clin. Dev. Immunol., 2012, 985646. doi: 10.1155/2012/985646.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Saji F., Samejima Y., Kamiura S., Koyama M. Dynamics of immunoglobulins at the feto-maternal interface. J. Rev. Reprod., 1999, Vol. 4, no. 2, pp. 81-89.</mixed-citation><mixed-citation xml:lang="en">Saji F., Samejima Y., Kamiura S., Koyama M. Dynamics of immunoglobulins at the feto-maternal interface. J. Rev. Reprod., 1999, Vol. 4, no. 2, pp. 81-89.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Semczuk-Sikora A., Krzyzanowski A., Stachowicz N., Robak J., Kraczkowski J., Kwiatek M., Semczuk M. Maternal serum concentration of angiogenic factors: PIGF, VEGF and VEGFR-1 and placental volume in pregnancies complicated by intrauterine growth restriction. Ginekologia Polska, 2007, Vol. 78, no. 10, pp. 783-786.</mixed-citation><mixed-citation xml:lang="en">Semczuk-Sikora A., Krzyzanowski A., Stachowicz N., Robak J., Kraczkowski J., Kwiatek M., Semczuk M. Maternal serum concentration of angiogenic factors: PIGF, VEGF and VEGFR-1 and placental volume in pregnancies complicated by intrauterine growth restriction. Ginekologia Polska, 2007, Vol. 78, no. 10, pp. 783-786.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. Measles cases hit record high in the European Region [Электронный ресурс]: сайт. Режим доступа: http://www.euro.who.int/en/media-centre/sections/press-releases/2018/measles-cases-hit-record-high-in-the-european-region (дата обращения: 18.02.19).</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Measles cases hit record high in the European Region [Electronic resource. Access mode: http://www.euro.who.int/en/media-centre/sections/press-releases/2018/measles-cases-hit-record-high-in-the-european-region (date of the application: 18.02.19]).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
